ϟ
DOI: 10.1093/annonc/mdt543
¤ OpenAccess: Bronze
This work has “Bronze” OA status. This means it is free to read on the publisher landing page, but without any identifiable license.
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
José Baselga,A. Manikhas,Javier Cortés,Antonio Llombart,L. Roman,Владимир Семиглазов,M. Byakhov,Lokanatha Dasappa,Salvatore Forenza,Ronald H. Goldfarb,Jeri Matera,Nozar Azarnia,Clifford A. Hudis,Marcel Rozencweig
Medicine
Trastuzumab
Metastatic breast cancer
2014
Loading...
- MLA
- APA
- Chicago
- IEEE
- Harvard
- BibTeX
Cite this:
Generate Citation
“Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer” is a paper by José Baselga A. Manikhas Javier Cortés Antonio Llombart L. Roman Владимир Семиглазов M. Byakhov Lokanatha Dasappa Salvatore Forenza Ronald H. Goldfarb Jeri Matera Nozar Azarnia Clifford A. Hudis Marcel Rozencweig published in 2014. It has an Open Access status of “bronze”. You can read and download a PDF Full Text of this paper here.